Enfusion, Inc.

NYSE:ENFN

11.09 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Revenue 201.611174.535150.349111.779.56559.027
Cost of Revenue 64.87457.64147.131.84521.35816.961
Gross Profit 136.737116.894103.24979.85558.20742.066
Gross Profit Ratio 0.6780.670.6870.7150.7320.713
Reseach & Development Expenses 26.72719.89317.163153.46.3184.146
General & Administrative Expenses 78.82664.63568.764150.61435.88816.625
Selling & Marketing Expenses 25.02920.41829.28651.7259.9277.426
SG&A 103.85585.05398.05202.33945.81524.051
Other Expenses 00-0.638-1.1850.082-0.003
Operating Expenses 130.582104.946115.213355.73952.13328.197
Operating Income 6.15511.948-11.964-275.8846.07413.869
Operating Income Ratio 0.0310.068-0.08-2.470.0760.235
Total Other Income Expenses Net 1.234-0.464-0.225-5.779-1.58-0.727
Income Before Tax 7.38911.484-12.189-281.6634.49413.142
Income Before Tax Ratio 0.0370.066-0.081-2.5220.0560.223
Income Tax Expense 4.5662.2311.0740.5790.4330.486
Net Income 2.8236.025-13.263-282.2424.06112.656
Net Income Ratio 0.0140.035-0.088-2.5270.0510.214
EPS 0.0190.1-0.16-4.30.0360.11
EPS Diluted 0.0130.072-0.16-4.30.0360.11
EBITDA 6.15521.935-5.62-271.9098.36515.023
EBITDA Ratio 0.0310.126-0.037-2.4450.1060.255